TeacherMitra.com
Dictionary
Dictionary
allow_url_fopen is ENABLED
Dictionary Search
Go Find!
xenon
Synonyms
Noun
1. Xe
2. atomic number 54, chemical element, element, noble gas, inert gas, argonon
Usage
Xenon Pharmaceuticals Inc. Rings the Opening Bell - Nasdaq
[144] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan
Xenon gas does not help elite climbers - UW Homepage
Deciphering the “Missing Xenon Paradox” in Celestial Bodies: A Multifaceted Perspective Toward Demystifying This Enigma - AGU Publications
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Recent Pullback And Strong Multi Year Returns - simplywall.st
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win - Clinical Trials Arena
JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE) - Yahoo Finance
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations - BioSpace
Krypton/Xenon separation at room temperature in a flexible coordinative framework sorbent - Nature
Xenon phase 3 epilepsy readout 'blows away' expectations, stock soars - Fierce Biotech
Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy - BioPharma Dive
Xenon Pharmaceuticals (XENE) director awarded RSUs, options and exercises vested RSUs - Stock Titan
Xenon (XENE) director receives RSUs, options and adds common shares - Stock Titan
Xenon Pharmaceuticals (XENE) director awarded RSUs, options and exercises RSUs - Stock Titan
Xenon Pharmaceuticals (XENE) director receives new RSUs, options and RSU vesting - Stock Titan
Xenon Pharmaceuticals (XENE) director receives RSUs, options and nets vested shares - Stock Titan
Xenon Pharmaceuticals (XENE) director exercises RSUs and gets new option award - Stock Titan
Xenon Pharmaceuticals (XENE) investors approve 2026 equity plan and pay votes - Stock Titan
Xenon Pharmaceuticals (XENE) director awarded RSUs, options and RSUs vest into shares - Stock Titan
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development - dicardiology.com
The First Xenon-Powered Everest Climb Is Coming This Spring - Climbing Magazine
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win - Yahoo Finance
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering - GlobeNewswire
Xenon’s seizure drug study reads out soon. Here’s what to expect - statnews.com
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why - Yahoo Finance
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing - The Motley Fool
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for - GlobeNewswire
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) - GlobeNewswire
Size-inverse molecular sieving xenon/krypton separation through cation-tuned gating effect within Linde Type A zeolites - Nature
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Yahoo Finance
Xenon tees up FDA filing after seizure med delivers 'home run' in Phase III - FirstWord Pharma
Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here - Yahoo Finance
A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase 3 X TOLE2 Success And Extended Cash Runway - Yahoo Finance
Xenon Presents Azetukalner Phase 3 Seizure Study Results - The Clinical Trial Vanguard
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results - GlobeNewswire
The Bull Case For Xenon Pharmaceuticals (XENE) Could Change Following Strong X-TOLE2 Data And FDA NDA Plans - simplywall.st
Xenon Pharmaceuticals Announces Closing of $747.5 Million - GlobeNewswire
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - Yahoo Finance
Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial - statnews.com
Xenon Pharmaceuticals surges 43.6% as Phase 3 azetukalner epilepsy data beats expectations | XENE Stock News - Quiver Quantitative
Xenon Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Nova release ‘X-Alps winner’ Xenon 3 - Cross Country Magazine
Xenon Pharmaceuticals stock surges 40% on positive trial data - Investing.com
Isomeric Nonpolar Amino Acid–Derived Metal–Organic Frameworks for Xenon/Krypton Separation - Wiley Online Library
Rab Xenon Synthetic Jacket Review - Switchback Travel
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Is Xenon Pharmaceuticals (XENE) Quietly Reframing Its Epilepsy Bet Through Equity Awards and New Data? - Yahoo Finance
RBC: Revolution, Xenon, Arrowhead among top takeover targets - Yahoo Finance
Xenon to Announce Topline Results from Phase 3 X-TOLE2 - GlobeNewswire
Xenon to Present at Upcoming Investor Conferences - GlobeNewswire
Janus Henderson reports 4.5% stake in Xenon Pharmaceuticals (XENE) filing - Stock Titan
Xenon Pharmaceuticals (NASDAQ: XENE) shows 5.78M-share holding, 6.26% - Stock Titan
Neuronal ‘off switch’ gets closer to reality - Nature
Worth the wait: Xenon’s azetukalner exceeds expectations in FOS - BioWorld News
Can Xenon Gas Really Replace Traditional Acclimatization on Mount Everest? - Global Rescue
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update - Yahoo Finance
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality - ChartMill
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE) - Seeking Alpha
EyeCare4Kids Partners With Xenon Ophthalmics to Expand Access to Comprehensive Vision Exams - VisionMonday.com
Can Xenon Help You Climb Everest Faster? These Scientists Aren't Buying the Hype. - Outside Magazine
Xenon Pharmaceuticals (XENE) director exercises options, now holds 10,641 shares - Stock Titan
Xenon Pharmaceuticals to Announce Topline Data from Phase 3 X-TOLE2 Study of Azetukalner for Focal Onset Seizures - Quiver Quantitative
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Xenon Pharmaceuticals Trying To Close In On Key Technical Benchmark - Investor's Business Daily
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know - The Motley Fool
What Do Recent Insider Sales at Xenon Pharmaceuticals Signal - Kavout
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - GlobeNewswire
Seven new Xenon hires get stock awards priced at $56.04 - Stock Titan
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data - The Motley Fool
Xenon Reports Q1 2026 Financial Results and Provides Business Update - Yahoo Finance
Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference - Yahoo Finance
AUXITO 9005 LED Headlight Bulbs, 12000LM 6500K Xenon White, HB3 Wireless, Pack Of 2 - aviglianonews.it
A Look At Xenon Pharmaceuticals (XENE) Valuation After Wolfe Research’s New Favorable Coverage - Yahoo Finance
Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout (NASDAQ:XENE) - Seeking Alpha
$500M stock sale: neuroscience drug maker Xenon tests market appetite - Stock Titan
Silver-infused zeolite efficiently separates xenon from krypton for industrial use - Phys.org
XENON Launches CIXL Pulsed Light System for Food Safety, Pathogen Control - Food Safety Magazine
Xenon Pharmaceuticals prices $650M public offering at $57/share - Investing.com
Biopharma bites: Salspera's IPO plans, plus $600M+ raises for Xenon, Dianthus - FirstWord Pharma
Xenon Pharmaceuticals Reports Significant Long-Term Efficacy of Azetukalner in Epilepsy at AES 2025 - Quiver Quantitative
Xenon Pharmaceuticals Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference in January 2026 - Quiver Quantitative
Jefferies raises Xenon Pharmaceuticals stock price target on epilepsy drug potential - Investing.com
Xenon Pharmaceuticals (XENE) boosts 2025 inducement equity plan share reserve - Stock Titan
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade - Investor's Business Daily
Xenon’s Azetukalner Confirms Phase III Efficacy Signal, Sets Up Mid-Year NDA Filing - Citeline News & Insights
Xenon Pharmaceuticals Stock Jumps as Analysts Raise Price Targets - StocksToTrade
Xenon's Phase 3 Supports A 'Buy' Despite Its Premium (NASDAQ:XENE) - Seeking Alpha
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 - GlobeNewswire
BofA raises Xenon Pharmaceuticals price target on trial success - Investing.com
Xenon lines up four investor conference presentations in Q2 2026 - Stock Titan
Cantor Fitzgerald raises Xenon Pharmaceuticals stock price target to $55 - Investing.com
Baird raises Xenon Pharmaceuticals price target to $97 on trial data - Investing.com
Stocks With Rising Relative Strength: Xenon Pharmaceuticals - Investor's Business Daily
List of 23 Acquisitions by Xenon Private Equity (Apr 2026) - Tracxn
Xenon Reports Q1 2026 Financial Results and Provides Business Update - GlobeNewswire
Stifel raises Xenon Pharmaceuticals stock price target on trial data - Investing.com
Xenon Pharmaceuticals Nets $707.7 Million in $57 Share Offering With Pre-Funded Warrants - TradingView
Xenon Pharmaceuticals (XENE) sets June 2, 2026 annual shareholder meeting and April 7 record date - Stock Titan
Foreign Language Equivalents
Foreign Language Equivalents of 'xenon'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
xenno, xennon, xenom, xenn, enon, zenon, cenon, xeon, xxenon, xnon, xenob, xeno, xenin, xwnon, xneon, xebon, xrnon, exnon, xenpn, xeenon, xemon, xenoon, xeonn, xenonn
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z